How much is Omnipotent Bio worth in 2026?

Omnipotent Bio has a current valuation of N/A based on their Early Stage VC round and secondary market data.

How much funding has Omnipotent Bio raised?

Omnipotent Bio has raised N/A in total funding across 1 funding rounds.

Omnipotent Bio

Biotechnology

Omnipotent Bio valuation and funding history | Last updated: August 1, 2023 | 1 funding rounds

Current Valuation

N/A

As of August 1, 2023

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC

Amount undisclosed

Last Funding

Aug 2023

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 1, 2023	Early Stage VC	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Omnipotent Bio is currently valued at N/A as of August 1, 2023.

Track Omnipotent Bio Valuation Updates

Get notified when Omnipotent Bio raises new funding or valuation changes

Explore More Data

Detailed analysis for Omnipotent Bio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Omnipotent Bio's valuation history, funding rounds, and growth metrics.

No credit card required

What is Omnipotent Bio Worth in 2026?

Omnipotent Bio is a leading private company in the Biotechnology sector. Track Omnipotent Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Omnipotent Bio Valuation is Determined

Private company valuations like Omnipotent Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.